top of page

Amy Giaramillo

UNil mio Giaramilloè il fondatore di Body Science LLC, un centro medico basato sulla scienza sviluppato con la missione di identificare la causa principale delle sindromi di salute. Malattia dei neuroni, disregolazione della tiroide, affaticamento surrenale, ADD/ADHD, autoimmunità, diabete, permeabilità intestinale e infertilità e poi li correggiamo.  Il nostro obiettivo è curare non solo medicare.  

 

Laureata alla Florida State University con una laurea in biologia e chimica, Amy ha oltre 21 anni di esperienza nel settore sanitario. È membro dell'American Academy of Anti-Aging (A4M) dal 2011 e in passato membro dell'Associazione per l'avanzamento della medicina riparativa (AARM).  

 

Amy ha una vasta esperienza di lavoro nei campi della biogenetica e della biotecnologia comprendendo il legame genetica-malattia, nonché nel campo della stimolazione cerebrale, dell'impianto e della neuromodulazione per le malattie neurodegenerative.

 

La sua conoscenza approfondita della biochimica, della genetica e della fisiologia, in quanto riguardano la salute, la guarigione e le interazioni ormonali, le ha fatto guadagnare il rispetto dei suoi colleghi nel campo della medicina riparativa e della medicina anti-invecchiamento.  

 

La sua esperienza con l'epigenetica ha portato al suo successo nell'arena della salute personalizzata e i protocolli diagnostici che Amy ha sviluppato svolgono un ruolo fondamentale nell'identificare e invertire i danni e ripristinare la salute.   

Conferenze

BodyScience Parkinson's Disease Treatments
01:24

BodyScience Parkinson's Disease Treatments

Parkinson's disease is a progressive neurodegenerative disorder that affects the nervous system, particularly the dopamine-producing neurons in the brain. It is characterized by symptoms that develop slowly over time and can vary from person to person. At BodyScience, we have a proven track record of success in treating neurodegenerative disorders, with a particular focus on Parkinson's disease. Our innovative treatments are built on years of research and clinical expertise, offering patients advanced therapeutic options that enhance quality of life. We are proud to be recognized for our dedication to delivering cutting-edge care and our personalized approach that addresses the unique needs of every individual. When it comes to Parkinson’s, BodyScience is a name you can trust for effective, results-driven treatment. We have several therapies already proven to help in neurodegenerative deceases, such as: https://www.bodyscience.life/fmt https://www.bodyscience.life/astrocytes https://www.bodyscience.life/stemcells https://www.bodyscience.life/molecular https://www.bodyscience.life/ketamine-als https://www.bodyscience.life/uv-light-therapy and more... For more information: https://www.bodyscience.life/parkinsons BodyScience 5975 Sunset Drive Suite 100 South Miami FL 33143 PHONE: 305-901-5888 www.bodyscience.life email: info@bodyscience.life Registration https://www.bodyscience.life/neuro FB Group https://www.facebook.com/groups/1008584079506823/ Youtube https://www.youtube.com/@bodysciencelife2562
New Therapies in ALS: Fecal Microbiota Transplant (FMT), Transcranial Magnetic Stimulation
01:03:55

New Therapies in ALS: Fecal Microbiota Transplant (FMT), Transcranial Magnetic Stimulation

Webinar June 27th 2024 (Subtitulos disponibles en Español) New Therapies in ALS: Fecal Microbiota Transplant FMT, Transcranial Magnetic Stimulation Summary - 🧑‍🔬 Introduction to BodyScience: Amy Jaramillo introduces herself and BodyScience's focus on neurodegenerative diseases, mentioning new developments in the field. - 🧬 New Strategies: Emphasizes the importance of new treatments and research in ALS, Parkinson's, and Alzheimer's, and the availability of these treatments. - 💡 Emerging Therapies: - Monoclonal Antibodies: Discusses recent research and their potential for treating neurodegenerative diseases. - Fecal Microbiota Transplant (FMT): Highlights recent studies showing significant improvements in ALS patients. - Transcranial Direct Current Stimulation (tDCS): Describes its potential to reconfigure brain pathways even after pathogen eradication. - Filgrastim: Explains its use in mobilizing bone marrow stem cells and reducing neuroinflammation. - 🧠 Astrocyte Protocol: Describes the shift in focus from motor neurons to glial cells and astrocytes, showing promising results in ALS patients. - 🔬 Research and Innovations: Stresses the continuous advancements and the clinic's role in implementing these therapies. - 🏥 Patient Stories: Shares success stories of patients showing significant improvements with new treatments. Insights Based on Numbers - Increase in Muscle Strength: Patients showed an increase in muscle circumference (5-9 cm) after FMT. - Functional Improvement Scores: ALS Functional Rating Scale scores improved from 15 to 20 in one patient and from 15 to 23 in another after FMT. - Reduction in Ventilator Dependence: FMT patients showed significant reduction in ventilator use, with one patient breathing independently after four weeks. Example Exploratory Questions 1. How does fecal microbiota transplant (FMT) help ALS patients regain muscle strength and improve breathing? 2. What role do astrocytes play in neurodegenerative diseases, and how does the Astrocyte Protocol target these cells? 3. How can monoclonal antibodies be used to treat neurodegenerative diseases like Alzheimer's and Parkinson's? BodyScience 5975 Sunset Drive Suite 100 South Miami FL 33143 PHONE: 305-901-5888 www.bodyscience.life email: info@bodyscience.life ALS Page https://www.bodyscience.life/als-program Registration https://www.bodyscience.life/registration FB Group https://www.facebook.com/groups/1008584079506823/ Youtube https://www.youtube.com/@bodysciencelife2562
ALS (Lou Gehrig's disease) Root Cause Analysis and Updated Strategies by Amy Jaramillo
01:33:18

ALS (Lou Gehrig's disease) Root Cause Analysis and Updated Strategies by Amy Jaramillo

ALS Lou Gehrig's Disease Root Cause Analysis and Updated Strategies by Amy Jaramillo Summary: 00:00:00 Amy explains the objective of the call, which is to discuss new strategies and results from their work, give a broad overview of what they're doing, and answer any questions. She emphasizes that she is not a physician, and this is not medical advice. 00:05:00 Amy discusses her approach to treating ALS, which she does not view as a disease but rather as an outcome of various causes. She emphasizes the importance of finding the right combination of treatments for each individual, as a monotherapy is unlikely to be effective. 00:10:00 Amy discusses her approach to treating ALS as a collection of manageable symptoms rather than an untreatable disease. She emphasizes the importance of identifying and addressing individual components such as infections, chemical exposures, and fungal overgrowth. 00:15:00 Amy discusses her shift in focus from repairing mitochondria in motor neurons to targeting the supporting cells, or Galil cells, surrounding motor neurons. She explains that these cells, which include oligodendrites, microglia, and astrocytes, are responsible for providing a large majority of mitochondria to motor neurons. 00:25:00 Amy discusses the role of serotonin and acetylcholine in improving symptoms of ALS, specifically in relation to emotion control, speaking, swallowing, and breathing. 00:30:00 Amy discusses the role of the Herpes Simplex 2 virus in modifying brain chemistry and its impact on ALS progression. The virus, which resides in the spine but has control switches in the brain, can increase serotonin and dopamine levels, particularly in the reward center related to sex. 00:35:00 Amy discusses the complex nature of ALS and the need to correct neurotransmitter pathways rather than focusing on a single location in the brain. She mentions the involvement of neurotransmitters such as Gaba, glutamine, acetylcholine, and serotonin in motor neuron damage. 00:40:00 Amy discusses the importance of IV medications and acetylcholine pathways in treating ALS. The speaker explains that they had observed significant improvements in a patient's voice and mobility after using IV therapies, and when they introduced a medication that blocked acetylcholine receptors 00:45:00 Amy discusses the importance of identifying the root cause of motor neuron damage in ALS before focusing on repair. She explains that the use of stem cells, while beneficial, is not a one-size-fits-all solution, and the timing and approach to their application are crucial. 00:50:00 Amy discusses a patient's improvement in speech and facial muscle control after a combination of transcranial stimulation, Vegas nerve component stimulation, and building mitochondria. She explains that just providing stimulation to the motor cortex alone may not be enough if the underlying issue is serotonergic to acetylcholine imbalance or ongoing infections. 00:55:00 Amy discusses the process of identifying potential root causes of motor neuron involvement for individuals with ALS. She explains that the first step is to schedule a Zoom call for a strategy session, during which they will discuss various factors such as infections, chemical and fungal exposures, genetics, nutritional status, and immune function. 01:00:00 Amy discusses the dynamic nature of the treatment plan for ALS patients. She emphasizes that the goal is to prevent worsening and improve symptoms, rather than following a strict protocol. Jaramillo shares her experience with patients who have shown improvement and explains that the approach is constantly evolving to achieve better outcomes in more people. 01:10:00 Amy explains the difference between brain stimulation and electric shock therapy in treating ALS. She notes that while both involve electrical currents, the waveforms and targets are vastly different. Brain stimulation aims to modulate specific waves in the motor cortex to stimulate nerve cells, unlike electric shock therapy, which indiscriminately zaps the brain. 01:15:00 Amy discusses the importance of addressing the root causes of ALS, specifically the Herpes Simplex 2 infection at the base of the spine, which alters human behavior and controls neurotransmitters in the brain. 01:20:00 Amy discusses the importance of proper nutrition, specifically a Mediterranean diet, for ensuring the initial startup of cellular processes. She emphasizes the role of glycolysis as the cell's starter and the need for a small portion of complex carbohydrates with a low glycemic index to support this process. 01:30:00 Amy concludes the discussion by acknowledging the large number of people interested in ALS and the progress made in neurodegenerative diseases in the last five years. BodyScience 5975 Sunset Drive Suite 100 South Miami FL 33143 PHONE: 305-901-5888 www.bodyscience.life email: info@bodyscience.life Registration https://www.bodyscience.life/registration
Explicación del protocolo de astrocitos. EMN/ELA - Parte II
52:18

Explicación del protocolo de astrocitos. EMN/ELA - Parte II

Escuche a Amy Jaramillo (Directora Científica) describir el éxito de nuestro Protocolo de Astrocitos (Presentación Traducida de Ingles a Español) Explicación del protocolo de astrocitos. EMN/ELA - Parte II Resumen - 👩‍🔬 Introducción: Amy Jaramillo se presenta y explica el objetivo de revisar el protocolo de astrocitos en el tratamiento de enfermedades de las neuronas motoras. - 💡 Nuevas Estrategias: - Mejoras en Síntomas: Destaca los resultados impresionantes en pacientes, incluyendo mejoras en voz, deglución, respiración y estado de ánimo. - Serotonina y Acetilcolina: Explica el papel de la serotonina en el estado de ánimo y cómo la acetilcolina regula la respuesta de lucha o huida, afectando los síntomas de las enfermedades de las neuronas motoras. - 🧠 Protocolo de Astro Cito: - TDP-43 Proteinopatía: Describe cómo la acumulación de proteínas TDP-43 limita la capacidad de las neuronas motoras. - Microglía y Mitocondrias: Enfatiza la importancia de las células microgliales y los astrocitos en la reparación de neuronas motoras, y cómo las mitocondrias dañadas afectan la función celular. - Infecciones y Toxinas: Señala que las infecciones y productos químicos como fluoruro, percloratos y bifenilos policlorados pueden dañar los astrocitos, afectando la salud neuronal. - 🧪 Innovaciones en Tratamiento: - Combinaciones de Terapias: La importancia de combinar medicamentos y tecnologías como la estimulación magnética transcraneal para mejorar los resultados en pacientes. - Protocolo en el Hogar: Detalles sobre cómo mantener saludables las mitocondrias y la implementación de protocolos en casa para apoyar a los astrocitos. Insights Basados en Números - Mejoras en Pacientes: Cinco pacientes mostraron mejoras notables en voz, fuerza de agarre y movilidad después de seguir el protocolo de astrocitos, con tres de ellos también recibiendo tratamiento con células madre. - Evidencia de Mejoras Continuas: Pacientes como Greg continúan mostrando mejoras en múltiples áreas sintomáticas tras varios meses de seguimiento. Ejemplos de Preguntas Exploratorias 1. ¿Cómo afectan las infecciones y los productos químicos a los astrocitos en pacientes con enfermedades de las neuronas motoras? 2. ¿Cuál es el papel de la acetilcolina en la regulación de la respuesta de lucha o huida y su impacto en las enfermedades de las neuronas motoras? 3. ¿Cómo pueden las tecnologías como la estimulación magnética transcraneal combinarse con medicamentos para tratar las enfermedades de las neuronas motoras? Somos una clínica médica funcional, enfocada en enfermedades neurodegenerativas y el rol del sistema inmunológico en esas enfermedades. BodyScience 5975 Sunset Drive Suite 100 South Miami FL 33143 PHONE: 305-901-5888 www.bodyscience.life email: info@bodyscience.life ALS Page https://www.bodyscience.life/als-program Registration https://www.bodyscience.life/registration FB Group https://www.facebook.com/groups/1008584079506823/ Youtube https://www.youtube.com/@bodysciencelife2562
Advancements in ALS Research Insights from Scientific Director Amy Jaramillo - March 20th 2024
39:54

Advancements in ALS Research Insights from Scientific Director Amy Jaramillo - March 20th 2024

Advancements in ALS Research Insights from Scientific Director Amy Jaramillo - March 20th 2024 00:00:00 Amy Jaramillo discusses her recent focus on new developments in ALS research, specifically in the area of neurodegenerative disease. She explains that her previous focus had been too narrow, solely on motor neurons, and she failed to recognize the role of supportive cells, or non-neuron cells, in motor neuron damage and disease. This shift in focus led her to discover the importance of microglia cells, which are non-neurons but play a crucial role in keeping neurons healthy by getting rid of infections and repairing damaged neurons. 00:05:00 Amy Jaramillo discusses her research on the asite protocol and its unexpected benefits. She shares that instead of just seeing speech improvements, they observed significant enhancements in hand strength, fine motor coordination, and walking, particularly for individuals with rigidity or spasticity. Jaramillo then explores ways to improve stem cell production and neuron repair, focusing on strategies used in oncology. She explains that some medications and radiation used in oncology destroy bone marrow, leading to an increase in stem cells and immune system support. 00:10:00 Amy Jaramillo discusses the use of stem cells in treating ALS and the importance of autophagy in allowing new healthy cells to replace damaged ones. She explains that autophagy strategies that work in individuals without chronic illnesses do not work in those with chronic conditions, and that shocking cells in individuals with chronic inflammation can worsen their condition. Jaramillo also mentions the addition of new strategies to the program to increase stem cell production, improve immune surveillance, and bolster the white cell community. She also discusses the potential damage to asites, which support neurons, and the role of halides in damaging them. 00:15:00 Amy discusses the importance of understanding the individual presentation of motor neuron disease and reverse engineering the condition. She mentions a case study of an individual with rigidity, fine motor coordination issues, speaking, swallowing, breathing issues, and mood-related symptoms, potentially indicating damage to astrocytes. 00:20:00 Amy Jaramillo discusses the use of ganglion blocks as a treatment for ALS (amyotrophic lateral sclerosis), a neurodegenerative disease. Jaramillo explains that she does not recommend ganglion blocks as a monotherapy due to their temporary effect, comparing it to using a dental block for tooth pain without addressing the underlying issue. Instead, the ALS center is focusing on improving the function of asites, which support motor neurons, using medications designed to increase mitochondrial health. 00:25:00 Amy Jaramillo discusses the benefits of exploring various areas of health and wellness, including traditional herbs and supplements. She mentions the example of mistletoe and its use in oncology, and emphasizes the importance of supporting mitochondrial function for individuals with ALS. Before implementing specific treatments, Jaramillo recommends focusing on general health and wellness by using supplements like sodium bicarb, chaperon one, and an amino acid powder. 00:30:00 Amy Jaramillo discusses the relationship between blood sugar dysfunction and neurodegenerative diseases, specifically ALS. She explains that motor neurons require sugar to function but may struggle to get it into the cells due to insulin or insulin receptor issues. This can lead to a higher risk of type 2 diabetes. When it comes to fruits, Jaramillo recommends a rainbow diet for maximum vitamin and mineral intake but cautions against consuming too much fruit due to their sugar content. 00:35:00 Amy Jaramillo discusses the importance of maintaining the right pH balance in the body for motor neuron function. She recommends using a combination of sodium bicarb and potassium bicarb to alkalinize the body, especially first thing in the morning and at the end of the day. Jaramillo also suggests consuming warm water with lemon as an effective way to alkalinize the body throughout the day. https://www.bodyscience.life/amy-bio Supplements mentioned in the webinar Chaperone1 https://www.biomeiqstore.com/products/chaperone-1 Extreme Aminos https://www.biomeiqstore.com/products/extreme-aminos Bicarbonate Supreme https://www.biomeiqstore.com/products/bicarbonate-supreme BodyScience 5975 Sunset Drive Suite 100 South Miami FL 33143 PHONE: 305-901-5888 www.bodyscience.life email: info@bodyscience.life ALS Page https://www.bodyscience.life/als-program Registration https://www.bodyscience.life/registration FB Group https://www.facebook.com/groups/1008584079506823/ Youtube https://www.youtube.com/@bodysciencelife2562
Does Lyme cause ALS and Astrocyte Protocol Update
01:17:28

Does Lyme cause ALS and Astrocyte Protocol Update

Does Lyme cause ALS and Astrocyte Protocol Update 00:00:00 Amy discusses the Astrocyte protocol and its potential relationship to Lyme disease and ALS. She explains that her center's primary focus is neurodegenerative diseases, specifically motor neuron disease like ALS. 00:05:00 Amy discusses their shift in focus from motor neurons to astrocytes, a non-neuron cell type, in understanding and treating motor neuron diseases like ALS. Astrocytes are crucial for proper motor neuron health as they supply mitochondria, calcium, and antioxidants to motor neurons. 00:10:00 Amy discusses the progress of individuals undergoing treatment for motor neuron disease using an Astrocyte protocol. The protocol targets Astrocytes, one of three cells in the G network responsible for keeping motor neurons healthy. 00:15:00 Amy discusses the role of infections, specifically Lyme disease, in motor neuron damage and ALS. The speaker explains that they have observed a high number of individuals with motor neuron disease or ALS who also have high antibodies for Lyme. However, their efforts to treat Lyme did not result in the long-term improvements they were hoping for. 00:20:00 Amy compares the accuracy of antibody and antigen tests in diagnosing Lyme disease. He uses the analogy of an eyewitness misidentifying a robber to explain the potential confusion and inaccuracy of antibody tests. 00:25:00 Amy discusses the complex relationship between various infections, toxins, and motor neuron disease. According to the speaker, having a history of infections like micoplasma, exposure to chlorinated and fluorinated compounds, and heavy metals can contribute to inflammation and potentially lead to motor neuron disease. 00:30:00 Amy discusses the potential link between infections, specifically Lyme disease, and neurodegenerative diseases such as ALS. The speaker explains that viruses like COVID-19 can damage the immune system, leading to the reactivation of opportunistic viruses like Epstein-Barr, which can cause inflammation and neurodegeneration. 00:35:00 Amy compares the role of a pit crew in maintaining a race car to the function of micral, oligodendrocytes, and astrocytes in maintaining healthy motor neurons. He explains that if these cells are not performing optimally, motor neuron damage and inability to function properly will occur. 00:45:00 Amy discusses the importance of considering various factors to determine the root cause of Lyme disease and its associated symptoms. He emphasizes the need to look at lab results, initial symptom locations, and progression speed to identify causal toxins and infections. 00:50:00 Amy discusses the complex relationship between infections, neurodegenerative diseases like Alzheimer's, ALS, and Parkinson's, and the role of stem cells in repairing damage. The speaker argues that in some cases, an infection like vericella-oster (the chickenpox and shingles virus) may not cause neurodegenerative disease at the moment of infection but rather decades later due to ongoing reactivations and resulting damage. 01:00:00 Amy discusses the role of genetics, infections, and toxins in the development of diseases such as ALS. Genetic predispositions play a significant role, specifically in relation to motor neuron oxidative damage and the ability to reduce oxidative damage. 01:05:00 Amy discusses the potential connection between herpes viruses, immune system dysfunction, and thyroid issues. He suggests that an individual's immune system's ability to control opportunistic infections may depend on factors such as the number of herpes viruses and other infections, as well as thyroid function. The speaker also mentions the possibility of heavy metal toxicity leading to thyroid dysfunction and, in turn, herpetic replication. 01:10:00 Amy discusses the importance of scheduling a consultation for individuals who believe their loved ones may benefit from the treatments offered. He mentions that each person requires unique medications and dosages, and that a Zoom call can be scheduled through the Body Science website to discuss potential testing and symptoms. The speaker then addresses a question about a woman diagnosed with ALS who has seen improvement after starting antibiotic treatment. 01:15:00 Amy discusses the potential reversibility of motor neuron disease, specifically in relation to the studies conducted at Tel Aviv University in 2021. The researchers found that reducing the amount of misfolded protein R (tdp43) in motor neurons allowed them to resume firing. BodyScience 5975 Sunset Drive Suite 100 South Miami FL 33143 PHONE: 305-901-5888 www.bodyscience.life email: info@bodyscience.life ALS Page https://www.bodyscience.life/als-program Registration https://www.bodyscience.life/registration FB Group https://www.facebook.com/groups/1008584079506823/ Youtube https://www.youtube.com/@bodysciencelife2562
bottom of page